WGS of the posttreatment tissue revealed that the ecDNA-driven hyperamplification of EGFR reached more than 80 copies, which likely amplified the wild-type EGFR allele (Fig. 6b), suggesting dual independent activating mechanisms of the MAPK pathway in this tumor (Fig. 6c). The gene discussed is EGFR; the disease is neoplasm.